Susan G. Kreissman
Expertise in
3
conditions
Expertise in
3
conditions

Overview

Susan Kreissman is a Pediatric Hematologist Oncology provider in Durham, North Carolina. Dr. Kreissman is highly rated in 3 conditions, according to our data. Her top areas of expertise are Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, Hepatoblastoma, Pediatric Low-Grade Glioma (pLGG), and Bone Marrow Aspiration.

Her clinical research consists of co-authoring 30 peer reviewed articles and participating in 49 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in NC
Board Certifications
American Board Of Pediatrics, Pediatric Hematology-Oncology
Fellowships
Pediatric Hematology-Oncology, Children's Hospital, Dana Farber Cancer Center (Massachusetts)
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Piedmont
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 4 Less Insurance Carriers -

Locations

Duke Children's Health Center Hematology/Oncology Clinic
2301 Erwin Rd, Durham, NC 27710
Other Locations
Duke Children's Hematology/Oncology Creekstone
4709 Creekstone Dr, Durham, NC 27703

Additional Areas of Focus

Dr. Kreissman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


49 Clinical Trials

Computerized Cognitive Training for Pediatric Brain Tumor Patients: A Pilot Study
A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphoblastic Lymphoma (T-LLy)
Randomized Phase 3 Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008) to Multiagent Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma
Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
A Randomized Phase 3 Study of Brentuximab Vedotin (SGN-35) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Young Adults
A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517) in Patients With Ph-like Tyrosine Kinase Inhibitor (TKI) Sensitive Mutations
Treatment of Children With All Stages of Hepatoblastoma With Temsirolimus (NSC#683864) Added to High Risk Stratum Treatment
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol
Neuroblastoma Biology Studies
A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients With Non-High-Risk Neuroblastoma
Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome
Renal Tumors Classification, Biology, and Banking Study
Key Adverse Events After Childhood Cancer
A Groupwide Pilot Study to Test the Tolerability and Biologic Activity of the Addition of Azacitidine (IND# 133688, NSC# 102816) to Chemotherapy in Infants With Acute Lymphoblastic Leukemia (ALL) and KMT2A(MLL) Gene Rearrangement
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-Trans Retinoic Acid
LEAHRN (Late Effects After High-Risk Neuroblastoma) Study
View 47 Less Clinical Trials
Similar Doctors
John J. Strouse
Expertise in
11
conditions
Pediatric Hematology Oncology
Expertise in
11
conditions
Pediatric Hematology Oncology

Duke Adult Comprehensive Sickle Cell Center - Clinic 2N

40 Duke Medicine Cir, 
Durham, NC 
 (0.3 miles away)
Languages Spoken:
English
Offers Telehealth

I became interested in medicine after studying tropical forest in college and realizing that I wanted more contact with people than trees. In medical school, I cared for children and adults with sickle cell disease and was inspired by the challenges and complexity of this chronic illness. I chose to train in both pediatric and adult hematology and now see both children and adults with non-malignant blood disorders. I joined Duke Health in July 2016 to direct the Adult Sickle Cell Program and focus on the care of children and adults with disorders of hemoglobin. Dr. Strouse is highly rated in 11 conditions, according to our data. His top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, Bone Marrow Aspiration, and Bone Marrow Transplant.

Expertise in
4
conditions
Pediatric Hematology Oncology
Expertise in
4
conditions
Pediatric Hematology Oncology
101 Manning Dr, 
Chapel Hill, NC 
 (9.6 miles away)
Languages Spoken:
English

Paul Monahan is a Pediatric Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Monahan is highly rated in 4 conditions, according to our data. His top areas of expertise are Hemophilia B, Blood Clots, Hemophilia A, and Hemophilic Arthropathy.

Jennifer Rothman
Expertise in
11
conditions
Pediatric Hematology Oncology
Expertise in
11
conditions
Pediatric Hematology Oncology
2100 Erwin Rd, 
Durham, NC 
 (0.2 miles away)
Languages Spoken:
English
Offers Telehealth

Jennifer Rothman is a Pediatric Hematologist Oncology provider in Durham, North Carolina. Dr. Rothman is highly rated in 11 conditions, according to our data. Her top areas of expertise are Pyruvate Kinase Deficiency, Anemia, Hemolytic Anemia, Congenital Hemolytic Anemia, and Splenectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kreissman's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile